SGPL1 and cystic fibrosis: Since all the piece of the puzzle fitted together, we moved to the identification of inhibitors that could inhibit both the human and the A. fumigatus orthologues of SPL in the perspective of developing potential drugs able to perform both anti-inflammatory and anti-microbial activities in CF (Cellini et al., 2023).